MCL1 and cancer: Additionally, MCL1 is known to cross-talk with multiple signal transduction pathways, e.g., EGFR and PI3K-AKT, thus cancer cells can utilize other survival mechanisms when MCL1 is suppressed, as possible resistance mechanisms.